StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Wednesday. The firm issued a sell rating on the stock.
Navidea Biopharmaceuticals Stock Performance
Shares of NAVB stock opened at $0.03 on Wednesday. The company has a 50 day moving average of $0.04 and a 200-day moving average of $0.05. Navidea Biopharmaceuticals has a 12-month low of $0.02 and a 12-month high of $0.17.
Navidea Biopharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Navidea Biopharmaceuticals
- Overbought Stocks Explained: Should You Trade Them?
- MarketBeat Week in Review – 5/13 – 5/17
- Why Invest in 5G? How to Invest in 5G Stocks
- Take-Two Interactive Software Offers 2nd Chance for Investors
- Best Stocks Under $5.00
- Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.